CTI Biopharma Corp
F:CEPS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CTI Biopharma Corp
F:CEPS
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CEPS's stock price target?
Not Available
CEPS doesn't have any price targets made by Wall Street professionals.
What is CTI Biopharma Corp's Revenue forecast?
Projected CAGR
-35%
For the last 8 years the compound annual growth rate for CTI Biopharma Corp's revenue is -1%. The projected CAGR for the next 4 years is -35%.